465 related articles for article (PubMed ID: 33378805)
1. [Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].
Wang LZ; Li JF; Wang TF; Xie YT; Fan ZQ; He YJ; Ouyang T
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):127-133. PubMed ID: 33378805
[No Abstract] [Full Text] [Related]
2. [Safety of breast-conserving treatment for triple-negative breast cancer].
Wang L; Ouyang T; Wang T; Xie Y; Fan Z; Fan T; Li J
Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):947-52. PubMed ID: 26850668
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method.
Wang L; He Y; Li J; Wang T; Xie Y; Fan Z; Ouyang T
Breast Cancer Res Treat; 2020 Oct; 183(3):717-728. PubMed ID: 32715444
[TBL] [Abstract][Full Text] [Related]
4. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
5. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
[TBL] [Abstract][Full Text] [Related]
6. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
7. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
8. [The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].
Li Y; Mu L; Ruan YX; Wang YT; Zhang D; Zhou H; Wang X
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):341-346. PubMed ID: 29860760
[No Abstract] [Full Text] [Related]
9. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
[No Abstract] [Full Text] [Related]
10. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
[No Abstract] [Full Text] [Related]
11. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.
Kindts I; Buelens P; Laenen A; Van Limbergen E; Janssen H; Wildiers H; Weltens C
Breast; 2017 Apr; 32():18-25. PubMed ID: 28012411
[TBL] [Abstract][Full Text] [Related]
12. Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy.
Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Jung KH; Gong G; Kim HH; Ahn SH; Ko B
JAMA Surg; 2020 Dec; 155(12):1142-1150. PubMed ID: 33052412
[TBL] [Abstract][Full Text] [Related]
13. [Factor analysis of diagnosis and surgical treatment of local regional recurrence in breast cancer patients].
Jin ZY; Lu YJ; Chen WG; Li YF; Chen XS; Shen KW
Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):366-372. PubMed ID: 31091592
[No Abstract] [Full Text] [Related]
14. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
[TBL] [Abstract][Full Text] [Related]
15. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
[TBL] [Abstract][Full Text] [Related]
16. Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.
Jeon YW; Choi JE; Park HK; Kim KS; Lee JY; Suh YJ
Breast Cancer Res Treat; 2013 Apr; 138(2):475-84. PubMed ID: 23456232
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients.
Zhang J; Yang C; Lei C; Zhang Y; Ji F; Gao H; Yang M; Zhang L; Li J; Zhu T; Li W; Zhuang X; Wang K
Breast; 2021 Aug; 58():10-17. PubMed ID: 33878598
[TBL] [Abstract][Full Text] [Related]
18. Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
Sun ZH; Chen C; Kuang XW; Song JL; Sun SR; Wang WX
Medicine (Baltimore); 2021 May; 100(18):e25880. PubMed ID: 33951002
[TBL] [Abstract][Full Text] [Related]
19. Is a higher boost dose of radiation necessary after breast-conserving therapy for patients with breast cancer with final close or positive margins?
Sadek BT; Homayounfar G; Abi Raad RF; Niemierko A; Shenouda MN; Keruakous AR; Specht MC; Taghian AG
Breast Cancer Res Treat; 2015 Nov; 154(1):71-9. PubMed ID: 26420403
[TBL] [Abstract][Full Text] [Related]
20. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
Laird J; Lok B; Siu C; Cahlon O; Khan AJ; McCormick B; Powell SN; Cody H; Wen HY; Ho A; Braunstein LZ
Ann Surg Oncol; 2018 Jan; 25(1):154-163. PubMed ID: 29094250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]